Pharmesis International Ltd (SGX:BFK) Share Price

Company Profile

Business description
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution, which refers to agency products and internally manufactured products which are marketed through the distribution arm. The company derives revenue from the sale of medicines to domestic customers in China.
Contact
5 Kallang Sector
No. 03-02
Singapore349279
SGP
T: +65 68460766
https://www.pharmesis.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees

Recommended

Muse models may just be the spark that the rirm needed in AI model development.

Malik Ahmed Khan, CFA | 13 April 2026

Despite headwinds our long-term outlook is unchanged.

Esther Holloway | 12 April 2026

We think the floundering stock price is not reflective of underlying asset value.

Brian Han | 10 April 2026

Index	Last price	Change	% Change
All Ordinaries	9,113.40	6.40	0.07%
CAC 40	8,228.98	30.62	-0.37%
DAX 40	23,744.91	59.04	-0.25%
Dow JONES (US)	47,677.46	239.11	-0.50%
FTSE 100	10,580.54	19.99	-0.19%
HKSE	25,660.85	232.69	-0.90%
NASDAQ	22,976.48	73.59	0.32%
Nikkei 225	56,502.77	421.34	-0.74%
NZX 50 Index	13,020.18	161.26	-1.22%
S&P 500	6,823.50	6.61	0.10%
S&P/ASX 200	8,926.00	14.20	0.16%
SSE Composite Index	3,988.56	2.33	0.06%